| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $34.7M | -19.6% |
| Cost of Revenue | $14.0M | +26.3% |
| Gross Profit | $20.7M | -35.4% |
| R&D Expense | $15.1M | -7.7% |
| SG&A Expense | $34.3M | -4.1% |
| Operating Income | -$31.5M | -38.6% |
| Pre-tax Income | -$33.9M | -34.0% |
| Income Tax | -$1.1M | -48.4% |
| Net Income | -$32.8M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $22.1M | -57.5% |
| Accounts Receivable | $5.7M | +25.2% |
| Inventory | $3.5M | -27.4% |
| Current Assets | $33.8M | -47.5% |
| Total Assets | $63.2M | -29.4% |
| Current Liabilities | $9.7M | -29.0% |
| Long-term Debt | $5.0M | — |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$28.2M | -101.6% |
| Capital Expenditures | $6.1M | +67.2% |
| Investing Cash Flow | -$6.5M | -50.8% |
| Financing Cash Flow | $5.0M | +593.5% |
| Free Cash Flow | -$34.3M | -94.5% |
| -33.6% |
| EPS (Basic) | -$0.75 | -31.6% |
| EPS (Diluted) | -$0.75 | -31.6% |
| Total Liabilities |
| $27.9M |
| +3.4% |
| Stockholders' Equity | $35.4M | -43.5% |